New Horizons for Sofidel in Oklahoma
Sofidel America, the U.S. subsidiary of the Italian paper manufacturer, is making a significant $775 million investment to expand its production facility in Inola, Oklahoma. This project will add an impressive 1 million square feet to the existing plant, increasing the overall footprint to nearly 3 million square feet. As a prominent player in the North American tissue market, this expansion is a strategic move to bolster its capacity and meet the growing demand for premium tissue products.
The Expansion Details
The expansion, which was unveiled in October last year, will feature a new tissue machine capable of producing 75,000 tons of tissue per year. Additionally, renovations will include an expanded pulp and parent reel storage area and a fully automated finished goods warehouse. Innovative technologies will also be integrated into the new facility, such as laser-guided vehicle systems for efficient internal logistics and automated loading systems to streamline operations.
Impact on Local Economy
The addition of this facility emphasizes Sofidel's commitment to the U.S. market, highlighting the Oklahoma site's strategic advantages due to its proximity to major transport routes and the Tulsa Port of Inola. This development is expected to create numerous job opportunities, further enhancing the local economy. Moreover, the expansion aligns with recent trends in the region, as Oklahoma attracts major investments from other industries, like the new $4 billion aluminum smelting plant being developed nearby.
The Bigger Picture in the Tissue Market
Sofidel's investment reflects broader trends within the tissue manufacturing industry, which has seen substantial growth in demand, especially for products catering to private labels. The company's efforts to establish a robust production footprint in North America have proven successful, making it the fourth-largest tissue manufacturer on the continent. The firm has expanded aggressively since entering the U.S. market in 2012, acquiring multiple facilities and expanding its production capabilities.
Future Prospects
With the $775 million expansion projected for completion by 2028, Sofidel aims to reinforce its market position and respond effectively to customer demands. As the demand for high-quality tissue products continues to rise, this investment signals positive growth prospects not only for Sofidel but also for the local manufacturing industry.
Add Row
Add
Write A Comment